Search Results
Mar 27, 2026, 15:30 ET QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
March 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, and October 31, 2025, inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 26, 2026, 16:37 ET QURE SHAREHOLDER ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
treatment.The recent reports follow the filing of a securities class action suit.Investors in uniQure (QURE) are encouraged to visit the Hagens Berman QURE Case Page to review the allegations in the pending litigation:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines - QURE
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-uniqure-nv-of-class-action-lawsuit-and-upcoming-deadlines--qure-302725659.htmlSOURCE
More news about: Pomerantz LLP
Mar 25, 2026, 09:00 ET Levi & Korsinsky Reminds uniQure N.V. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026 - QURE
March 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 19:17 ET uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed; April 13, 2026, Lead Plaintiff Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V. Investor SummaryWho: uniQure N.V. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 24, 2026, 12:30 ET QURE SHAREHOLDER ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
treatment.The recent reports follow the filing of a securities class action suit.Investors in uniQure (QURE) are encouraged to visit the Hagens Berman QURE Case Page to review the allegations in the pending litigation:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 24, 2026, 09:00 ET QURE Shareholder Alert: uniQure N.V. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
March 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of uniQure N.V. (NASDAQ: QURE).
More news about: The Gross Law Firm
Mar 23, 2026, 20:55 ET QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
March 23, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, and October 31, 2025, inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 22, 2026, 08:43 ET QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi, LLP, a leading national securities law firm, is investigating potential claims against UniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 20, 2026, 22:30 ET uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
uniQure N.V. (NasdaqGS: QURE) ("uniQure" or the "Company"), if they purchased or otherwise acquired the Company's shares between September 24, 2025 and October 31, 2025, inclusive
More news about: ClaimsFiler
Mar 20, 2026, 16:30 ET QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
treatment.The recent reports follow the filing of a securities class action suit.Investors in uniQure (QURE) are encouraged to visit the Hagens Berman QURE Case Page to review the allegations in the pending litigation:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 04:23 ET QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 20, 2026, 03:23 ET uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of QURE during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 19, 2026, 17:40 ET Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V. Investor SummaryWho: uniQure N.V. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 19, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines - QURE
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-uniqure-nv-of-class-action-lawsuit-and-upcoming-deadlines--qure-302717089.htmlSOURCE
More news about: Pomerantz LLP
Mar 18, 2026, 12:19 ET QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data
treatment. The recent reports follow the filing of a securities class action suit.Investors in uniQure (QURE) are encouraged to visit the Hagens Berman QURE Case Page to review the allegations in the pending litigation:
More news about: Hagens Berman Sobol Shapiro LLP
Mar 18, 2026, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE
March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 17, 2026, 16:52 ET QURE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi, LLP, a leading national securities law firm, is investigating potential claims against uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 17, 2026, 09:00 ET QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm
March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of uniQure N.V. (NASDAQ: QURE).
More news about: The Gross Law Firm
Mar 16, 2026, 15:05 ET QURE INVESTOR ALERT: uniQure Faces Securities Class Action Over AMT-130 Clinical Trial Design - Hagens Berman
www.hbsslaw.com/investor-fraud/qureuniQure N.V. (QURE) Securities Class Action: uniQure develops treatments for patients suffering from rare and other devastating
More news about: Hagens Berman Sobol Shapiro LLP
Mar 16, 2026, 01:23 ET QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
March 16, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, and October 31, 2025, inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 13, 2026, 21:57 ET uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
uniQure N.V. (NasdaqGS: QURE) ("uniQure" or the "Company"), if they purchased or otherwise acquired the Company's shares between September 24, 2025 and October 31, 2025, inclusive
More news about: Kahn Swick & Foti, LLC
Mar 13, 2026, 14:34 ET uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? Affected uniQure N.V. Investor SummaryWho: uniQure N.V. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 12, 2026, 15:24 ET QURE ALERT: FDA Reportedly Accuses uniQure of Pushing "Distorted" and "Manipulated" Data For "Failed" AMT-130 Drug Amid Pending Securities Class Action - Hagens Berman
QURE Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 12, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is updating its investigation into uniQure
More news about: Hagens Berman Sobol Shapiro LLP
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines - QURE
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-uniqure-nv-of-class-action-lawsuit-and-upcoming-deadlines--qure-302710642.htmlSOURCE
More news about: Pomerantz LLP